Broadcast

Landmark Data in Intermediate PE HI-PEITHO and Clinical Implications

Erik Klok, Lukas Hobohm, Melanie Ferreira

Watch time: 1h 7m 30s

Broadcast

Optimising Cath Lab Management to Scale TAVI

Kristoffer Russell, Henryk Dreger, Rajesh Kharbanda , et al

Broadcast

Redo TAVI Cases from Sizing to Implant

Daniel Blackman, Arif Khokhar,

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

ORBITA-CTO Viewpoint

Published:

01 June 2026

Citation:

US Cardiology Review 2026;20:e08.

Valvular Heart Disease in Heart Failure with Preserved Ejection Fraction

Published:

27 May 2026

Citation:

Cardiac Failure Review 2026;12:e14.

Complete Revascularisation in STEMI: Do We Really Buy It?

Published:

06 May 2026

Citation:

Interventional Cardiology 2026;21:e12.

DynamX Performance in Complex Coronaries: OCT Study

Published:

28 April 2026

Citation:

Interventional Cardiology 2026;21:e11.